INSA releases Gripenet platform results for respiratory infection surveillance

The participatory surveillance electronic platform allows tracking respiratory health indicators in Portugal.

Generic image of a computer screen displaying graphs and data about respiratory infections, with a blurred Portuguese flag in the background.
AI

Generic image of a computer screen displaying graphs and data about respiratory infections, with a blurred Portuguese flag in the background.

The National Institute of Health Doctor Ricardo Jorge (INSA) has released the results of the Gripenet platform, a participatory surveillance system monitoring acute respiratory infections in Portugal based on citizen self-reported data.

The results from the electronic platform Gripenet, managed by INSA, are now available. This platform monitors the occurrence of acute respiratory infections through information reported by residents in Portugal, allowing for the tracking of key indicators obtained from participatory surveillance.
The release of the results area represents an important step in bringing the project closer to the participating community. Through this tool, any citizen can follow the evolution of relevant indicators and better understand the contribution of participatory surveillance to monitoring respiratory infections in the country.
Results are updated weekly, reflecting the information shared by participants. Regular participation from all registered users is essential to ensure the quality and representativeness of the data. Weekly reporting is a simple and quick process, taking less than a minute when there are no symptoms and only a few minutes when symptoms are present.
Created in 2004 by the Gulbenkian Institute of Science (IGC) and recognized for "good practices" by the Agency for Administrative Modernization (AMA) in 2009, Gripenet aggregated data from various European countries within the Influenzanet network. It was transferred to INSA in 2015 and reactivated in December 2025, following a period of inactivity after the COVID-19 pandemic.
Based on information from the official source: INSA - Instituto Nacional de Saúde Doutor Ricardo Jorge (16/10/2026)